Dr. Olshansky is a clinical cardiac electrophysiologist who is directed several academic electrophysiology training programs and is presently in clinical practice evaluating patients with rhythm ...

Join Us When you become a member of the American College of Cardiology, you join a global community of cardiovascular professionals driven to transform cardiovascular care and improve heart health.

A new joint Scientific Statement from the American Heart Association (AHA) and the ACC provides new and updated clinical guidance on how to assess risk when considering competitive sports ...

SGLT2 inhibitors may slow the progression of nonsevere aortic stenosis (AS), according to a study published Feb. 19 in JACC: Cardiovascular Interventions. In this multicenter observational study, ...

We want to hear from you. Tell us what you think here or leave a comment on the app's iTunes or Google Play page. The updated ASCVD Risk Estimator Plus uses up-to-date ACC clinical policy and user ...

In the rapidly evolving health care landscape, acute coronary syndromes (ACS) continue to be a leading cause of morbidity and mortality worldwide. Each year, an estimated 1.2 million individuals in ...

Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, ...

Women with peripartum cardiomyopathy (PPCM) had lower than expected rates of morbidity and mortality with a subsequent pregnancy (SSP), according to a prospective registry study published Feb. 12 in ...

A unique blend of forum and network, the Cardiovascular (CV) Team Member Section and Leadership Council is advancing ACC's efforts to identify and address gaps in areas of professional importance to ...

A unique international task force, comprised of representatives from cardiology and cardiothoracic societies as well as patient representatives, has developed the first standardized set of measures ...

Atrial fibrillation catheter ablation (AFCA) improved clinical outcomes compared with medical treatment alone, and early AFCA was associated with better outcomes than late AFCA, particularly decreased ...

Pulmonary embolism (PE) continues to challenge clinicians with its complex presentation and potential for rapid deterioration. As the third leading cause of cardiovascular mortality in the U.S.